NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
In this issue, highlights from the American Society of Clinical Oncology and European Haematology Association Annual...
This CPD module gives a detailed overview of the presentation, diagnosis, and latest treatment options...
In this issue, highlights from the 2023 Gathering Around Cancer as well as national and international...
Acute myeloid leukaemia (AML) is an aggressive form of blood cancer that is derived from the...
Welcome to the latest edition of Update Oncology and Haematology. Despite the ongoing pressure on healthcare...
Acnew study published in Blood Advances demonstrates that patients with haematological...
Chimeric antigen receptor (CAR) T-cell therapy is a highly personalised technology whereby a patient’s...
Haematological complications continue to represent a major source of morbidity and mortality during
While still generally incurable, there are a range of treatment approaches for chronic lymphocytic...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT